According to the company, the AccuVax Vaccine Management System streamlines vaccine workflow, saves nursing time, minimizes vaccine waste, safeguards vaccine potency, and helps protect against medical errors.
Vaccines are one of the most significant public health successes. Yet, lapses in handling can render a vaccine ineffective and may leave people unprotected or needing revaccination, according to the Centers for Disease Control and Prevention.
Inventory losses due to power failure, improper storage and expired doses are common, and have created challenges for even the most advanced practices and health systems.
According to the company, AccuVax offers key advantages over conventional vaccine refrigeration and storage practices.
The system automates time-consuming storage, handling, and documentation tasks. It also dramatically simplifies compliance with CDC guidelines, as well as the requirements of the federally funded vaccine program.
AccuVax is the purpose-built vaccine supply management system that automates product control and integrity, minimises risks of incorrect vaccine delivery, and optimises office work flow so that providers can focus on care delivery.
It is an integrated solution that includes hardware, software, online access, software updates, training, optional integrations, technical support and maintenance.
TruMed Systems, a medical technology company developing innovative point-of-care supply management systems for healthcare professionals.
AstraZeneca launches online platform to expand patient access to medications
Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments
GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
LakeShore Biopharma receives Nasdaq delisting determination letter
Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15
GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand
Novavax COVID-19 vaccine approved in US
WHO and UNICEF deploy PharmaJet's Tropis ID system in Afghanistan polio campaign
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement